Authors
This author initiated 90 original pathways:
This author contributed to 103 pathways:
This author contributed to 103 pathways:
This author contributed to the following 2 pathways with new drafts currently in review:
Nsalomonis
- ORCiD: 0000-0001-9689-2469
- Wikidata: Q89864869
Communities
Pathways
This author initiated 90 original pathways:
This author contributed to 103 pathways:
This author contributed to 103 pathways:
- Cell cycle - WP179 (Homo sapiens)
- Transcriptional activation by NRF2 in response to phytochemicals - WP3 (Homo sapiens)
- Pre-implantation embryo - WP3527 (Homo sapiens)
- Dopaminergic neurogenesis - WP2855 (Homo sapiens)
- Heart development - WP2067 (Mus musculus)
- Alpha 6 beta 4 signaling pathway - WP244 (Homo sapiens)
- Notch signaling - WP268 (Homo sapiens)
- Small ligand GPCRs - WP247 (Homo sapiens)
- Androgen receptor signaling pathway - WP138 (Homo sapiens)
- EGF/EGFR signaling pathway - WP437 (Homo sapiens)
- mRNA processing - WP411 (Homo sapiens)
- Eukaryotic transcription initiation - WP405 (Homo sapiens)
- Myometrial relaxation and contraction pathways - WP289 (Homo sapiens)
- Peptide GPCRs - WP24 (Homo sapiens)
- Complement activation - WP545 (Homo sapiens)
- Calcium regulation in cardiac cells - WP536 (Homo sapiens)
- Monoamine GPCRs - WP58 (Homo sapiens)
- Prostaglandin synthesis and regulation - WP98 (Homo sapiens)
- Nucleotide GPCRs - WP80 (Homo sapiens)
- mRNA processing - WP123 (Caenorhabditis elegans)
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706 (Homo sapiens)
- Fatty acid beta-oxidation 1 - WP39 (Drosophila melanogaster)
- Glial cell differentiation - WP2276 (Homo sapiens)
- Statin pathway - WP1 (Mus musculus)
- mRNA processing - WP467 (Danio rerio)
- Myometrial relaxation and contraction pathways - WP385 (Mus musculus)
- mRNA processing - WP310 (Mus musculus)
- mRNA processing - WP142 (Drosophila melanogaster)
- Myometrial relaxation and contraction pathways - WP140 (Rattus norvegicus)
- Pluripotent stem cell differentiation pathway - WP2848 (Homo sapiens)
- Spinal cord injury - WP2431 (Homo sapiens)
- Allograft rejection - WP2328 (Homo sapiens)
- Regulation of actin cytoskeleton - WP523 (Mus musculus)
- TGF-beta signaling pathway - WP366 (Homo sapiens)
- TNF-alpha signaling pathway - WP231 (Homo sapiens)
- Spinal cord injury - WP2433 (Rattus norvegicus)
- Statin inhibition of cholesterol production - WP430 (Homo sapiens)
- Alzheimer's disease and miRNA effects - WP2059 (Homo sapiens)
- Wnt signaling pathway and pluripotency - WP399 (Homo sapiens)
- Cardiac progenitor differentiation - WP2406 (Homo sapiens)
- Arrhythmogenic right ventricular cardiomyopathy - WP2118 (Homo sapiens)
- Beta-oxidation meta-pathway - WP372 (Rattus norvegicus)
- Fatty acid beta-oxidation 3 - WP25 (Drosophila melanogaster)
- Fatty acid beta-oxidation meta-pathway - WP209 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 3 - WP499 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 2 - WP148 (Caenorhabditis elegans)
- Proteasome degradation - WP470 (Caenorhabditis elegans)
- Striated muscle contraction pathway - WP383 (Homo sapiens)
- Mesodermal commitment pathway - WP2857 (Homo sapiens)
- Pathogenic Escherichia coli infection - WP2272 (Homo sapiens)
- Eukaryotic transcription initiation - WP177 (Drosophila melanogaster)
- Heart development - WP1591 (Homo sapiens)
- Fatty acid beta-oxidation 1 - WP126 (Caenorhabditis elegans)
- Eukaryotic transcription initiation - WP518 (Caenorhabditis elegans)
- Wnt signaling pathway and pluripotency - WP723 (Mus musculus)
- Eukaryotic transcription initiation - WP567 (Mus musculus)
- Calcium regulation in cardiac cells - WP553 (Mus musculus)
- GPCRs, class B secretin-like - WP456 (Mus musculus)
- GPCRs, other - WP41 (Mus musculus)
- Prostaglandin synthesis and regulation - WP374 (Mus musculus)
- GPCRs, small ligand - WP353 (Mus musculus)
- GPCRs, class C metabotropic glutamate, pheromone - WP327 (Mus musculus)
- GPCRs, peptide - WP234 (Mus musculus)
- G protein signaling pathways - WP232 (Mus musculus)
- Complement activation, classical pathway - WP200 (Mus musculus)
- GPCRs, class A rhodopsin-like - WP189 (Mus musculus)
- GPCRs, class C metabotropic glutamate, pheromone - WP501 (Homo sapiens)
- GPCRs, class A rhodopsin-like - WP455 (Homo sapiens)
- G protein signaling pathways - WP35 (Homo sapiens)
- GPCRs, class B secretin-like - WP334 (Homo sapiens)
- GPCRs, other - WP117 (Homo sapiens)
- MAPK signaling pathway - WP510 (Saccharomyces cerevisiae)
- Eukaryotic transcription initiation - WP425 (Saccharomyces cerevisiae)
- Cell cycle and cell division - WP414 (Saccharomyces cerevisiae)
- Hematopoietic stem cell differentiation - WP2849 (Homo sapiens)
- Synaptic vesicle pathway - WP2267 (Homo sapiens)
- Neural crest differentiation - WP2064 (Homo sapiens)
- G protein signaling pathways - WP73 (Rattus norvegicus)
- mRNA processing - WP529 (Rattus norvegicus)
- Proteasome degradation - WP519 (Mus musculus)
- Striated muscle contraction - WP316 (Rattus norvegicus)
- Glucocorticoid metabolism - WP305 (Rattus norvegicus)
- Prostaglandin synthesis and regulation - WP303 (Rattus norvegicus)
- Proteasome degradation - WP302 (Rattus norvegicus)
- Proteasome degradation - WP281 (Drosophila melanogaster)
- Proteasome degradation - WP183 (Homo sapiens)
- Small ligand GPCRs - WP161 (Rattus norvegicus)
- Proteasome degradation - WP158 (Saccharomyces cerevisiae)
- Statin pathway - WP145 (Rattus norvegicus)
- Insulin signaling - WP439 (Rattus norvegicus)
- Spinal cord injury - WP2432 (Mus musculus)
- Ectoderm differentiation - WP2858 (Homo sapiens)
- MAPK cascade - WP422 (Homo sapiens)
- Mapk cascade - WP251 (Mus musculus)
- Endoderm differentiation - WP2853 (Homo sapiens)
- Monoamine GPCRs - WP570 (Mus musculus)
- Monoamine GPCRs - WP276 (Rattus norvegicus)
- Nucleotide GPCRs - WP207 (Mus musculus)
- Gene regulatory network modelling somitogenesis - WP2854 (Homo sapiens)
- Adipogenesis - WP236 (Homo sapiens)
- G1 to S cell cycle control - WP413 (Mus musculus)
- Nucleotide GPCRs - WP502 (Rattus norvegicus)
- Peptide GPCRs - WP131 (Rattus norvegicus)
This author contributed to the following 2 pathways with new drafts currently in review:
